Page 2 - Massimo Caputi News Today

WEDNESDAY, Dec. 29, 2021 (HealthDay News) -- In an update that illustrates just how challenging it is to track the spread of a fast-moving virus, the U.S. Centers for Disease

WEDNESDAY, Dec. 29, 2021 (HealthDay News) -- In an update that illustrates just how challenging it is to track the spread of a fast-moving virus, the U.S. Centers for Disease

WEDNESDAY, Dec. 29, 2021 (HealthDay News) -- In an update that illustrates just how challenging it is to track the spread of a fast-moving virus, the U.S. Centers for Disease

WEDNESDAY, Dec. 29, 2021 (HealthDay News) -- In an update that illustrates just how challenging it is to track the spread of a fast-moving virus, the U.S. Centers for Disease

Variant is now believed to account for roughly 59% of all COVID cases. That could mean that a significant number of hospitalizations in mid-December were driven by the delta variant.

Delta, not Omicron, was the dominant variant in the United States in the week ending Dec. 18, the C.D.C. said.

Why didn’t the US detect omicron cases sooner?

Intesa Sanpaolo has made 1 billion euros available to support the recovery of small- and medium-sized enterprises in Italy tourism sector.

Florida Atlantic University researchers test for COVID-19 in saliva January 14, 2021 at 4:10 PM EST - Updated January 14 at 4:10 PM Researchers at Florida Atlantic University in Boca Raton are finding easier ways to test for COVID-19. The different technology is being shared with medical communities across the country. Professor Massimo Caputi said the technology behind testing for COVID-19 is changing. FAUs Charles E. Schmidt College of Medicine has found a way simpler way to test for COVI...

FAU researchers develop simplified, rapid SARS-CoV-2 detection protocol To properly monitor and help curb the spread of COVID-19, several millions of diagnostic tests are required daily in just the United States alone. There is still a widespread lack of COVID-19 testing in the U.S. and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. The current gold standard for COVID-19 diagnostic testing i...